12 Best Extremely Profitable Stocks to Buy Right Now

Page 7 of 11

5. United Therapeutics Corporation (NASDAQ:UTHR)

TTM Net Profit Margin: 40.44%

Number of Hedge Fund Holders: 43

Analyst Upside Potential: 35.10% 

United Therapeutics Corporation (NASDAQ:UTHR) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 15, Analyst Joseph Thome from TD Cowen maintained a Buy rating on United Therapeutics Corporation (NASDAQ:UTHR) with a price target of $400.

The analyst noted that he is optimistic about the company’s upcoming Phase III trial results for Tyvaso, which treats idiopathic pulmonary fibrosis. He believes the drug could show significant clinical benefits due to its unique mechanism and positive prior data. Thome noted the INCREASE Trial demonstrated the drug’s potential to improve lung function in IPF patients.

Moreover, the analyst also appreciated United Therapeutics Corporation’s (NASDAQ:UTHR) financial performance, noting that the recent quarterly revenue exceeded expectations driven by solid sales of main products like Remodulin and Orenitram.

United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company that develops and markets therapies primarily for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

Page 7 of 11